Skip to content
GLP-1 Scorecard
Menu
Graded #235

FuturHealth

FuturHealth Inc. is a San Diego-based telehealth weight management brand offering brand-name Ozempic, Wegovy (injection AND oral pill), Mounjaro, Zepbound, and Foundayo (orforglipron oral pill, added Q2 2026) plus clinician-discretionary compounded GLP-1/GIP combinations, dispensed through US-based licensed pharmacies.

Visit FuturHealth ↗We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$199/mo (compounded)
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Yes

Weigh FuturHealth against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value60/100
Dose & formulation81/100
Clinical oversight67/100
Labs & monitoring61/100
Fulfillment62/100
Contract terms55/100

Strengths

  • LegitScript Certified and HITRUST Certified
  • Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
  • Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
  • Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths

Where it loses points

  • Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
  • BBB complaints describe recurring charges without medication received — confirm cancellation flow first
  • Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
  • Pricing not shown until after the qualification questionnaire or portal login
  • Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber

Bottom line — Grade C

Best for: Shoppers who want brand-name and compounded GLP-1s with registered-dietitian coaching.

Ranked #235 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Visit FuturHealth ↗

Closest here

The rankings grading nearest FuturHealth — the realistic shortlist.

Zeuss#232

Zeuss is a multi-vertical telehealth platform offering compounded semaglutide and tirzepatide for weight loss alongside TRT, HRT, skin, and hair services.

FMmeds#233

FMmeds is a Manhattan Beach-based DTC telehealth platform selling compounded semaglutide and tirzepatide co-formulated with vitamin B12, with no membership fee and a free initial visit billed only on approval.

Eloria#234

Eloria is a clinician-led GLP-1 weight-loss telehealth platform operated by Arora Health & Aesthetics.

Healthicare#236

Healthicare is a GLP-1 telehealth platform offering both compounded options and a full brand-name menu — Ozempic, Wegovy, Mounjaro, and Zepbound — on a single account.

NowPatient#237

NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

Options Medical Weight Loss#238

Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month, plus NAD+ injections at $199/month.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect FuturHealth's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on FuturHealth's site. Not medical advice; see our disclosure.

← Back to the scorecard